|1.||Yang, Cheng: 1 article (04/2015)|
|2.||Dong, Quan-Feng: 1 article (04/2015)|
|3.||Zhang, Qian: 1 article (04/2015)|
|4.||Zheng, Ming-Sen: 1 article (04/2015)|
|5.||Chen, Jia-Jia: 1 article (04/2015)|
|6.||Wang, Xue-Yin: 1 article (04/2015)|
|7.||Hoai, Nguyen To: 1 article (09/2011)|
|8.||Sasaki, Akiyoshi: 1 article (09/2011)|
|9.||Kakuchi, Toyoji: 1 article (09/2011)|
|10.||Satoh, Toshifumi: 1 article (09/2011)|
11/01/1986 - "The dose-dependent hypothermia associated with sulfolane treatment was controlled in Experiment I and a replication study (Experiment II) by testing under isothermic conditions. "
01/01/1989 - "Systemic exposure of the rabbit to sulfolane results in hypothermia; however, the mechanism of this thermoregulatory effect is unknown. "
01/01/1988 - "The magnitude of the hypothermia was similar at these two Tas, indicating the sulfolane-treated rabbits had some control over Tc. "
11/01/1986 - "In addition, sulfolane produced an ambient temperature- and dose-dependent hypothermia. "
06/01/1986 - "By undergoing an autonomically and behaviorally mediated decrease in body temperature (i.e., regulated hypothermia), sulfolane-treated mice appear to enhance their chance of survival."
11/01/1976 - "In rodents oral or parenteral administration of sulfolane (tetrahydrothiophene-1,1-dioxide) produced hyperactivity, followed by clonic-tonic convulsions. "
11/01/1976 - "Sulfolane-induced convulsions in rodents."
11/01/1986 - "Audiogenic seizures were elicited in nearly half of the 800 mg/kg animals in both Experiments I and II. Sulfolane-induced hypothermia, maximal at 3 hours, partially protected against AG seizure characteristics. "
11/01/1986 - "Sulfolane dosages that alter seizure susceptibility were determined using audiogenic (AG), pentylenetetrazol (PTZ) and hippocampal afterdischarge (AD) seizure models. "
11/01/1986 - "Sulfolane effects on audiogenic, pentylenetetrazol and afterdischarge seizure activity."
|3.||Dehydration (Water Stress)
|4.||AIDS-Related Complex (ARC)